Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016.

Miriam HeinigMalte BraitmaierUlrike Haug

Published in: Pharmacoepidemiology and drug safety (2021)

For most types of MHT and all age groups, prevalence declined considerably between 2004 and 2016 in Germany. The cumulative dose per MHT user also decreased, suggesting a trend towards a shorter duration of use.

Keyphrases

current status
primary care
risk factors
mesenchymal stem cells
bone marrow
cell therapy